Menu
GWAS Study

Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.

Hoffmann TJ, Passarelli MN, Graff RE et al.

28139693 PubMed ID
GWAS Study Type
47118 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HT
Hoffmann TJ
PM
Passarelli MN
GR
Graff RE
EN
Emami NC
SL
Sakoda LC
JE
Jorgenson E
HL
Habel LA
SJ
Shan J
RD
Ranatunga DK
QC
Quesenberry CP
CC
Chao CR
GN
Ghai NR
AD
Aaronson D
PJ
Presti J
NT
Nordström T
WZ
Wang Z
BS
Berndt SI
CS
Chanock SJ
MJ
Mosley JD
KR
Klein RJ
MM
Middha M
LH
Lilja H
MO
Melander O
KM
Kvale MN
KP
Kwok PY
SC
Schaefer C
RN
Risch N
VD
Van Den Eeden SK
WJ
Witte JS
Chapter II

Abstract

Summary of the research findings

Prostate-specific antigen (PSA) levels have been used for detection and surveillance of prostate cancer (PCa). However, factors other than PCa-such as genetics-can impact PSA. Here we present findings from a genome-wide association study (GWAS) of PSA in 28,503 Kaiser Permanente whites and 17,428 men from replication cohorts. We detect 40 genome-wide significant (P<5 × 10-8) single-nucleotide polymorphisms (SNPs): 19 novel, 15 previously identified for PSA (14 of which were also PCa-associated), and 6 previously identified for PCa only. Further analysis incorporating PCa cases suggests that at least half of the 40 SNPs are PSA-associated independent of PCa. The 40 SNPs explain 9.5% of PSA variation in non-Hispanic whites, and the remaining GWAS SNPs explain an additional 31.7%; this percentage is higher in younger men, supporting the genetic basis of PSA levels. These findings provide important information about genetic markers for PSA that may improve PCa screening, thereby reducing over-diagnosis and over-treatment.

28,503 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

47118
Total Participants
GWAS
Study Type
Yes
Replicated
2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals
Replication Participants
Hispanic or Latin American, European, East Asian, African American or Afro-Caribbean
Ancestry
U.S., Sweden
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.